Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
The purpose of this study is to determine the safety and maximum tolerated dose, pharmacokinetics, and anti-neoplastic response of AVN-944 in patients with advanced hematologic malignancies.
Acute Leukemia|Chronic Leukemia|Multiple Myeloma|Hodgkin's Lymphoma|Non-Hodgkin's Lymphoma|Waldenstrom's Macroglobulinemia
DRUG: AVN-944 capsules for oral administration
The purpose of this study is to determine the safety and maximum tolerated dose, pharmacokinetics, and anti-neoplastic response of AVN-944 in patients with advanced hematologic malignancies.